Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression.

Abstract excerpt

Duchenne muscular dystrophy (DMD) is a genetic and progressive neuromuscular disorder caused by mutations and deletions in the dystrophin gene. Although there is currently no cure, one promising treatment for DMD is aimed at increasing endogenous levels of utrophin A to compensate functionally for the lack of dystrophin. Recent studies from our laboratory revealed that heparin treatment of mdx mice activates p38...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cyclooxygenase 2
• Share to Diaphragm